It has undergone a lot of clinical testing (the STEP trial program included more than 4,500 people) that shows it works and is safe, which supports regulatory submissions in big countries
doi: 10.3390/nu8020068 27
the risk of unintended apoptosis remains
GH is also expressed in other areas of the brain, such as the cortex, hippocampus, cortex, caudate nucleus, and retinal areas (307), as is the GH receptor, IGF-1, and the IGF-1 receptor, where it is thought that these mediate neuroprotective and regenerative functions (308)
Patients who dosed 1-2 hours before their largest daily meal experienced 18% greater satiety extension compared to random-timing dosing
Regulatory Status and Quality Control One important point often overlooked in marketing: AOD9604 is not FDAapproved for fat loss or aesthetic use